Eyesight to the blind: Second Sight prices $32m IPO

Second Sight Medical, maker of the Argus II 'bionic eye,' prices its initial public offering at $9 per share, hoping to raise nearly $32 million in its public trading debut today.

Second Sight Medical said today that it expects to reap nearly $32 million today when its shares debut on the public market.

Second Sight Medical Products Inc.

News Well, Initial Public Offering (IPO), Optical/Ophthalmic

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1Hkv5E5